Vir Biotechnology, Inc.

VIR Nasdaq CIK: 0001706431

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1800 OWENS STREET, SAN FRANCISCO, CA, 94158
Mailing Address 1800 OWENS STREET, SAN FRANCISCO, CA, 94158
Phone 415-906-4324
Fiscal Year End 1231
EIN 812730369

Financial Overview

FY2025 FY

$74.20M
Revenue

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report April 2, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
4 Insider stock transaction report March 24, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
8-K Current report of material events March 4, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
8-K Current report of material events March 2, 2026 View on SEC
4 Insider stock transaction report February 26, 2026 View on SEC
8-K Current report of material events February 26, 2026 View on SEC

Annual Reports

10-K February 23, 2026
  • Strategic collaborations with major pharmaceutical partners (Astellas, Sanofi, GSK) are crucial for pipeline development and commercialization.
  • Focused clinical-stage immunology company developing innovative treatments for serious infectious diseases using proprietary technology platforms.
View Analysis

Insider Trading

STRONG SELL 6 insiders 21 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.